<DOC>
	<DOC>NCT01884012</DOC>
	<brief_summary>In this randomized-controlled, cross-over trial the investigators test the effect of long-term oxygen therapy (&gt; 16h/day) given for 5 weeks with a wash-out period between phases of 2 weeks on exercise performance and quality of life and many physiological parameters in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension.</brief_summary>
	<brief_title>Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<criteria>Inclusion criteria: Adult patients with established diagnosis of pulmonary arterial or chronic thromboembolic pulmonary hypertension (class I and IV according to the latest WHO classification scheme of Dana Point 2008) on optimized medical therapy and in stable condition for at least 4 weeks, who desaturate in the 6 minute walking test by =4% to values &lt;92%. Exclusion criteria: Patients in unstable conditions requiring frequent therapeutic adaption pregnant women patients with pulmonary venous hypertension due to left heart diseases patients with relevant concomitant lung disease and severe daytime hypoxemia</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>